The Essure ProcedureThe Essure Procedure is an Office Tubal Occlusion, with no abdominal incision. In November 2002, the FDA granted approval to the Essure Permanent Birth Control device, a small metallic implant placed into the fallopian tubes through hysteroscopic guidance. The device requires the use of alternate contraception for a 3-month period after insertion and radiologic confirmation of a tubal occlusion. Most common side effects were cramping in 20% and nausea/vomiting in 8% of women (during placement). More serious side effects included expulsion (2.2%) and uterine perforation (1.5%). Advantages include lower cost and avoidance of abdominal scar. Call Advanced OB/GYN Care at (860) 409-1933 |